Stock Fundamentals

SMMT.US Logo

SMMT.US - Current Price

$16.19

Company Information

▼
Company Name
Summit Therapeutics PLC
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US86627T1088
CIK: 0001599298
CUSIP: 86627R102
Currency: USD
Full Time Employees: 159
Phone: 305 203 2034
Website: https://www.smmttx.com
Fiscal Year End: December
IPO Date: Mar 05, 2015
Description:

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.

Address:

601 Brickell Key Drive, Miami, FL, United States, 33131

Directors & Officers

▼
Name Title Year Born
Mr. Robert W. Duggan Co-CEO & Executive Chairman 1944
Dr. Mahkam Zanganeh D.D.S., M.B.A. Co-CEO, President & Director 1970
Mr. Manmeet Singh Soni CPA COO, CFO & Director 1978
Prof. Dame Kay Davies DBE, FRS CBE Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor 1951
Mr. Bhaskar Anand Chief Accounting Officer 1977
Mr. Nathan LiaBraaten Senior Director of Investor Relations NA
Mr. Dave Gancarz Chief Business & Strategy Officer NA
Dr. Fong Clow Chief Biometrics Officer NA
Dr. Urte Gayko Ph.D. Chief Regulatory, Quality & Pharmacovigilance Officer 1971
Dr. Allen S. Yang M.D., Ph.D. Head of R&D Strategy 1968

Shares Statistics

▼
Shares Outstanding: 744.44M
Shares Float: 102.55M
% Insiders: 8,605.30%
% Institutions: 1,445.30%
Short % Float: 27.39%

Valuation Metrics

▼
Enterprise Value: $12.01B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $12.05B
EBITDA: $-934.99M
PEG Ratio: $0.00
Book Value: $0.26
Earnings/Share: $-1.23
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -152.88%
ROE (TTM): -292.49%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.18 N/A 10,000.00%
Sep 30, 2025 -0.23 -0.10 N/A -12,432.17%
Jun 30, 2025 -0.12 -0.09 N/A -3,333.33%
Mar 31, 2025 -0.07 -0.07 N/A 73.31%
Dec 31, 2024 -0.07 -0.08 N/A 1,250.00%
Sep 30, 2024 -0.08 -0.07 N/A -1,428.57%
Jun 30, 2024 -0.09 -0.06 N/A -5,000.00%
Mar 31, 2024 -0.06 -0.06 N/A 0.00%
Dec 31, 2023 -0.04 -0.05 N/A 2,000.00%
Sep 30, 2023 -0.03 N/A N/A N/A
Jun 30, 2023 -0.02 N/A N/A N/A
Mar 31, 2023 -1.43 -1.43 N/A 0.00%
Dec 31, 2022 -0.07 -0.07 N/A 0.00%
Sep 30, 2022 -0.14 -0.14 N/A 0.00%
Jun 30, 2022 -0.17 -0.17 N/A 0.00%
Mar 31, 2022 -0.22 -0.22 N/A 0.00%
Dec 31, 2021 -0.28 -0.28 N/A 0.00%
Sep 30, 2021 -1.00 -0.29 N/A -24,482.76%
Jun 30, 2021 -1.35 -0.27 N/A -40,000.00%
Mar 31, 2021 -1.05 -0.21 N/A -40,000.00%
Dec 31, 2020 -0.90 -0.18 N/A -40,000.00%
Sep 30, 2020 -1.24 -0.01 N/A -1,230,000.00%
Jun 30, 2020 -1.15 -0.02 N/A -565,000.00%
Mar 31, 2020 -0.02 -0.02 N/A 600.00%
Sep 30, 2019 -0.22 -0.40 N/A 4,500.00%
Mar 31, 2019 -0.20 -0.16 N/A -2,500.00%
Dec 31, 2018 -0.35 -0.24 N/A -4,583.33%
Sep 30, 2018 -0.65 -0.31 N/A -10,967.74%
Jun 30, 2018 2.12 -0.51 N/A 51,568.63%
Mar 31, 2018 -0.52 -0.75 N/A 3,066.67%
Sep 30, 2017 -0.20 -0.58 N/A 6,551.72%
Jun 30, 2017 1.10 0.35 N/A 21,428.57%
Mar 31, 2017 -0.10 -0.17 N/A 4,352.94%
Dec 31, 2016 -0.50 N/A N/A N/A
Sep 30, 2016 -0.45 3.01 N/A -11,495.02%
Jun 30, 2016 -0.65 -0.65 N/A 0.00%
Mar 31, 2016 -0.55 -0.86 N/A 3,604.65%
Sep 30, 2015 -0.59 N/A N/A N/A
Jun 30, 2015 -0.52 N/A N/A N/A
Mar 31, 2015 -0.11 N/A N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $104.86M $N/A $435.56M $46.81M $388.75M
2023-12-31 $71.43M $N/A $202.95M $125.26M $77.69M
2022-12-31 $348.61M $N/A $664.17M $537.51M $126.65M
2021-12-31 $71.79M $N/A $113.37M $30.09M $83.28M
2020-12-31 $66.42M $N/A $102.50M $23.05M $79.45M
2019-12-31 $49.96M $N/A $75.46M $14.34M $61.12M
2018-12-31 $35.23M $N/A $78.39M $22.59M $55.80M
2017-12-31 $28.45M $N/A $76.38M $62.40M $13.98M
2016-12-31 $35.08M $N/A $46.98M $51.35M $-4.37M
2015-12-31 $23.22M $N/A $35.71M $5.62M $30.10M
2014-12-31 $16.97M $N/A $29.22M $6.67M $22.55M
2013-12-31 $3.35M $N/A $10.94M $3.08M $7.85M
2012-12-31 $5.34M $N/A $6.91M $2.41M $4.50M
2011-12-31 $3.26M $N/A $6.12M $2.34M $3.78M
2010-12-31 $5.14M $N/A $8.06M $2.24M $5.82M
2009-12-31 $9.72M $N/A $18.38M $5.15M $13.22M
2008-12-31 $3.92M $N/A $20.09M $7.77M $12.33M
2007-12-31 $20.06M $N/A $69.38M $15.30M $54.08M
2006-12-31 $35.87M $N/A $46.44M $6.33M $40.11M
2005-12-31 $22.55M $N/A $25.87M $2.49M $23.38M
2004-12-31 $26.66M $N/A $26.88M $350.21K $26.53M
2003-12-31 $145.96K $N/A $145.96K $3.65K $142.31K

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Oct 21, 2025 N/A N/A N/A N/A N/A N/A
Oct 21, 2025 N/A N/A N/A N/A N/A N/A
Oct 21, 2025 N/A N/A N/A N/A N/A N/A
Sep 11, 2025 N/A N/A N/A N/A N/A N/A
Sep 11, 2025 N/A N/A N/A N/A N/A N/A
Sep 10, 2025 N/A N/A N/A N/A N/A N/A
Sep 10, 2025 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist